maldi-tof analysis on the sequenom massarray platform Search Results


methylation analysis results from the maldi-tof massarray  (Sequenom)
90
Sequenom methylation analysis results from the maldi-tof massarray
Median methylation levels for NKX2-5 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the NKX2-5 gene; (B) NKX2-5 _M1 median methylation level; (C) NKX2-5 _M2 median methylation level; (D) NKX2-5 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; <t>M,MassARRAY</t> amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).
Methylation Analysis Results From The Maldi Tof Massarray, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/methylation analysis results from the maldi-tof massarray/product/Sequenom
Average 90 stars, based on 1 article reviews
methylation analysis results from the maldi-tof massarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
snps panel genotyping by maldi-tof mass spectrometry on sequenom massarray platform  (Sequenom)
90
Sequenom snps panel genotyping by maldi-tof mass spectrometry on sequenom massarray platform
Median methylation levels for NKX2-5 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the NKX2-5 gene; (B) NKX2-5 _M1 median methylation level; (C) NKX2-5 _M2 median methylation level; (D) NKX2-5 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; <t>M,MassARRAY</t> amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).
Snps Panel Genotyping By Maldi Tof Mass Spectrometry On Sequenom Massarray Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snps panel genotyping by maldi-tof mass spectrometry on sequenom massarray platform/product/Sequenom
Average 90 stars, based on 1 article reviews
snps panel genotyping by maldi-tof mass spectrometry on sequenom massarray platform - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
allele discrimination by maldi-tof mass spectrometry platform sequenom massarray(r)  (Sequenom)
90
Sequenom allele discrimination by maldi-tof mass spectrometry platform sequenom massarray(r)
Median methylation levels for NKX2-5 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the NKX2-5 gene; (B) NKX2-5 _M1 median methylation level; (C) NKX2-5 _M2 median methylation level; (D) NKX2-5 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; <t>M,MassARRAY</t> amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).
Allele Discrimination By Maldi Tof Mass Spectrometry Platform Sequenom Massarray(R), supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/allele discrimination by maldi-tof mass spectrometry platform sequenom massarray(r)/product/Sequenom
Average 90 stars, based on 1 article reviews
allele discrimination by maldi-tof mass spectrometry platform sequenom massarray(r) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
maldi-tof polymerase chain reaction sequenom massarray platform  (Sequenom)
90
Sequenom maldi-tof polymerase chain reaction sequenom massarray platform
Median methylation levels for NKX2-5 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the NKX2-5 gene; (B) NKX2-5 _M1 median methylation level; (C) NKX2-5 _M2 median methylation level; (D) NKX2-5 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; <t>M,MassARRAY</t> amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).
Maldi Tof Polymerase Chain Reaction Sequenom Massarray Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/maldi-tof polymerase chain reaction sequenom massarray platform/product/Sequenom
Average 90 stars, based on 1 article reviews
maldi-tof polymerase chain reaction sequenom massarray platform - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Median methylation levels for NKX2-5 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the NKX2-5 gene; (B) NKX2-5 _M1 median methylation level; (C) NKX2-5 _M2 median methylation level; (D) NKX2-5 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; M,MassARRAY amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).

Journal: BMC Medical Genomics

Article Title: DNA methylation status of NKX2-5, GATA4 and HAND1 in patients with tetralogy of fallot

doi: 10.1186/1755-8794-6-46

Figure Lengend Snippet: Median methylation levels for NKX2-5 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the NKX2-5 gene; (B) NKX2-5 _M1 median methylation level; (C) NKX2-5 _M2 median methylation level; (D) NKX2-5 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; M,MassARRAY amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).

Article Snippet: The accuracy of the methylation analysis results from the MALDI-TOF MassARRAY (Sequenom) were confirmed by pyrosequencing and bisulfite sequencing PCR (BSP) [ ].

Techniques: Methylation, Amplification, MANN-WHITNEY

Median methylation levels for GATA4 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the GATA4 gene; (B) The sequence shown represents a 500 base pair fragment (positions -392 – 107) in the 5′-UTR of GATA4 ; (C) GATA4 _M median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; M,MassARRAY amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).

Journal: BMC Medical Genomics

Article Title: DNA methylation status of NKX2-5, GATA4 and HAND1 in patients with tetralogy of fallot

doi: 10.1186/1755-8794-6-46

Figure Lengend Snippet: Median methylation levels for GATA4 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the GATA4 gene; (B) The sequence shown represents a 500 base pair fragment (positions -392 – 107) in the 5′-UTR of GATA4 ; (C) GATA4 _M median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; M,MassARRAY amplicon; The region between arrows, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).

Article Snippet: The accuracy of the methylation analysis results from the MALDI-TOF MassARRAY (Sequenom) were confirmed by pyrosequencing and bisulfite sequencing PCR (BSP) [ ].

Techniques: Methylation, Sequencing, Amplification, MANN-WHITNEY

Median methylation levels for HAND1 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the HAND1 gene; (B) HAND1 _M1 median methylation level; (C) HAND1 _M2 median methylation level; (D) HAND1 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; M,MassARRAY amplicon; The region between arrow, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).

Journal: BMC Medical Genomics

Article Title: DNA methylation status of NKX2-5, GATA4 and HAND1 in patients with tetralogy of fallot

doi: 10.1186/1755-8794-6-46

Figure Lengend Snippet: Median methylation levels for HAND1 in TOF patients and controls. (A) The schematic represents the distribution of the CpG site and CpG island in the HAND1 gene; (B) HAND1 _M1 median methylation level; (C) HAND1 _M2 median methylation level; (D) HAND1 _M3 median methylation level. All of the values represent the median with the interquartile range. TSS, Transcription Start Sites; red vertical line, CpG sites; red thick bars, CpG islands; M,MassARRAY amplicon; The region between arrow, target amplicon. * p < 0.05, ** p < 0.01, *** p < 0.001 (Mann–Whitney test).

Article Snippet: The accuracy of the methylation analysis results from the MALDI-TOF MassARRAY (Sequenom) were confirmed by pyrosequencing and bisulfite sequencing PCR (BSP) [ ].

Techniques: Methylation, Amplification, MANN-WHITNEY